FDA Approvals
ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease
Endpoints News
1h ago
FDA Approval
UpDoc, Tempus AI and Atman Health will participate in a new program that aims to build FDA-authorized agentic AI tools to care for people with heart disease, the federal government announced Wednesday. Called ADVOCATE, the ...
Discussion
Sign in to join the discussion. Comments loading…